v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net loss $ (4,314,000) $ (14,102,000)
Less: loss from discontinued operations, net of taxes of $0 (436,000) (622,000)
Loss from continuing operations, net of taxes (3,878,000) (13,480,000)
Adjustments to reconcile loss from continuing operations to cash used in operating activities:    
Depreciation and amortization 3,394,000 2,986,000
Amortization of debt issuance costs 27,000 164,000
Deferred tax expense (benefit) 105,000 (3,095,000)
Provision for (recovery of) bad debt reserves 85,000 (336,000)
(Gain) loss on disposal of property and equipment (1,000) 16,000
Impairment loss on tangible assets 672,000 1,816,000
Impairment loss on intangible assets 8,288,000
Issuance of common stock for services 161,000 178,000
Stock-based compensation 96,000 69,000
Changes in operating assets and liabilities of continuing operations    
Restricted cash 35,000
Accounts receivable 41,000 (140,000)
Unbilled receivables (1,554,000) 1,808,000
Prepaid expenses, inventories and other assets 293,000 2,225,000
Accounts payable, accrued expenses and unearned revenue 914,000 (1,869,000)
Cash provided by (used in) continuing operations 355,000 (1,335,000)
Cash used in discontinued operations (464,000) (710,000)
Cash used in operating activities (109,000) (2,045,000)
Cash flows from investing activities:    
Purchases of property and equipment (200,000) (104,000)
Proceeds from sale of property and equipment 7,000 30,000
Proceeds from/(payment to) finite risk sinking fund 5,845,000 (76,000)
Cash provided by (used in) investing activities of continuing operations 5,652,000 (150,000)
Cash provided by investing activities of discontinued operations 52,000 68,000
Cash provided by (used in) investing activities 5,704,000 (82,000)
Cash flows from financing activities:    
Repayments of revolving credit borrowings (34,979,000) (41,223,000)
Borrowing on revolving credit 31,176,000 44,137,000
Proceeds from issuance of common stock upon exercise of warrants/options 156,000
Release of proceeds for stock subscription for Perma-Fix Medical S.A. previously held in escrow 64,000
Payment of debt issuance costs (97,000)
Principal repayments of long term debt (914,000) (1,199,000)
Principal repayments of long term debt-related party (1,000,000)
Cash (used in) provided by financing activities of continuing operations (4,717,000) 838,000
Effect of exchange rate changes on cash 14,000 (1,000)
Increase (decrease) in cash 892,000 (1,290,000)
Cash at beginning of period 163,000 1,435,000
Cash at end of period 1,055,000 145,000
Supplemental disclosure:    
Interest paid 252,000 309,000
Income taxes paid $ 17,000 $ 41,000

Source